UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2021

~~QUARTERLY~~☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the ~~quarterly period ended December 31, 2020~~

☐ ~~TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934~~

~~For the~~ transition period from __________ to __________

Commission File Number: 001-38029

AKOUSTIS TECHNOLOGIES, INC.

(Exact name of registrant as specified in its charter)

Delaware		33-1229046
(State or other jurisdiction of		~~(IRS Employer~~
incorporation or organization)		(IRS Employer Identification No.)

9805 Northcross Center Court, Suite A
Huntersville, NC		28078
(Address of principal executive offices)		(Postal Code)

Registrant’s telephone number, including area code: 1-704-997-5735

Securities registered under Section 12(b) of the Act:

Title of Each Class:		Trading Symbol		Name of each exchange on which registered:
Common Stock, $0.001 par value		AKTS		The Nasdaq Stock Market LLC (Nasdaq Capital Market)

Securities registered under Section 12(g) of the Act:

None

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated filer	☒	Smaller reporting company	☒
		Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act) Yes ☐ No ☒

As of ~~January 25,~~April 26, 2021, there were ~~42,392,915~~50,374,194 shares of the registrant’s common stock, $0.001 par value per share, issued and outstanding.

AKOUSTIS TECHNOLOGIES, INC.

FORM 10-Q

FOR THE QUARTERLY PERIOD ENDED ~~DECEMBER~~MARCH 31, ~~2020~~2021

TABLE OF CONTENTS

			Page No.

PART I — FINANCIAL INFORMATION


ITEM 1.	FINANCIAL STATEMENTS		1

Condensed Consolidated Balance Sheets as of ~~December~~March 31, ~~2020~~2021 and June 30, 2020 (unaudited)			1

Condensed Consolidated Statements of Operations for the three and ~~six~~nine months ended ~~December~~March 31, ~~2020~~2021 and ~~2019~~2020 (unaudited)			2

Condensed Consolidated Statements of Changes in Stockholders’ Equity for the three and ~~six~~nine months ended ~~December~~March 31, ~~2020~~2021 and ~~2019~~2020 (unaudited)			3

Condensed Consolidated Statements of Cash Flows for the ~~six~~nine months ended ~~December~~March 31, ~~2020~~2021 and ~~2019~~2020 (unaudited)			5

Notes to the Condensed Consolidated Financial Statements (unaudited)			6

ITEM 2.	MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS		19

ITEM 3.	QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK		25

ITEM 4.	CONTROLS AND PROCEDURES		25

PART II — OTHER INFORMATION


ITEM 1.	LEGAL PROCEEDINGS		26

ITEM 1A.	RISK FACTORS		26

ITEM 2.	UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS	26	27

ITEM 3.	DEFAULTS UPON SENIOR SECURITIES	26	27

ITEM 4.	MINE SAFETY DISCLOSURES	26	27

ITEM 5.	OTHER INFORMATION	26	27

ITEM 6.	EXHIBITS	26	27

EXHIBIT INDEX		27	28

SIGNATURES		28	29

PART I - FINANCIAL INFORMATION

ITEM 1.FINANCIAL STATEMENTS.

Akoustis Technologies, Inc.

Condensed Consolidated Balance Sheets
(In thousands, except share data)
(Unaudited)

December 31, June 30,
2020 2020
Assets
Assets:
Cash and cash equivalents $ 47,685 $ 44,308
Accounts receivable 746 351
Inventory 651 136
Other current assets 1,851 1,408
Total current assets 50,933 46,203

Property and equipment, net 25,080 23,605

Intangibles, net 586 544

Operating lease right-of-use asset, net 589 699
Restricted cash 100 100
Other assets 282 282
Total Assets $ 77,570 $ 71,433

Liabilities and Stockholders’ Equity

Current Liabilities:
Accounts payable and accrued expenses $ 4,570 $ 5,899
Deferred revenue 57 —
Operating lease liability - current 250 231
Short term loans payable 594 —
Current convertible notes payable, net 9,795 —
Total current liabilities 15,266 6,130

Long-term Liabilities:
Convertible notes payable, net 14,351 21,628
Operating lease liability - non-current 342 472
Loans payable 1,010 1,591
Other long-term liabilities 117 117
Total long-term liabilities 15,820 23,808

Total Liabilities 31,086 29,938

Stockholders’ Equity
Preferred stock, par value $0.001: 5,000,000 shares authorized; none issued and outstanding — —
Common stock, $0.001 par value; 100,000,000 shares authorized; 41,399,075 and 37,990,380 shares issued and outstanding at December 31, 2020 and June 30, 2020, respectively 41 38
Additional paid in capital 173,918 145,072
Accumulated deficit (127,475 ) (103,615 )
Total Stockholders’ Equity 46,484 41,495
Total Liabilities and Stockholders’ Equity $ 77,570 $ 71,433

	March 31,			June 30,
	2021			2020
Assets
Assets:
Cash and cash equivalents	$	90,392		$	44,308
Accounts receivable		1,620			351
Inventory		1,446			136
Other current assets		1,572			1,408
Total current assets		95,030			46,203

Property and equipment, net		28,755			23,605

Intangibles, net		579			544

Operating lease right-of-use asset, net		531			699
Restricted cash		—			100
Other assets		282			282
Total Assets	$	125,177		$	71,433

Liabilities and Stockholders’ Equity
Current Liabilities:
Accounts payable and accrued expenses	$	5,163		$	5,899
Deferred revenue		123			—
Operating lease liability - current		260			231
Short term loans payable		1,218			—
Total current liabilities		6,764			6,130

Long-term Liabilities:
Convertible notes payable, net		—			21,628
Operating lease liability - non-current		274			472
Long term loans payable		392			1,591
Other long-term liabilities		117			117
Total long-term liabilities		783			23,808

Total Liabilities		7,547			29,938

Stockholders’ Equity
Preferred stock, par value $0.001: 5,000,000 shares authorized; none issued and outstanding		—			—
Common stock, $0.001 par value; 100,000,000 shares authorized; 50,374,194 and 37,990,380 shares issued and outstanding at March 31, 2021 and June 30, 2020, respectively		50			38
Additional paid in capital		255,230			145,072
Accumulated deficit		(137,650	)		(103,615	)
Total Stockholders’ Equity		117,630			41,495
Total Liabilities and Stockholders’ Equity	$	125,177		$	71,433

See accompanying notes to the condensed consolidated financial statements

Akoustis Technologies, Inc.

Condensed Consolidated Statements of Operations

(In thousands, except per share data)

(Unaudited)

For the Three
Months Ended
December 31,
2020 For the Three
Months Ended
December 31,
2019 For the Six
Months Ended
December 31,
2020 For the Six
Months Ended
December 31,
2019
Revenue
Revenue with customers $ 1,308 $ 518 $ 1,944 $ 1,061

Cost of revenue 2,602 787 4,251 1,123

Gross profit (loss) (1,294 ) (269 ) (2,307 ) (62 )

Operating expenses
Research and development 5,566 4,897 11,946 9,967
General and administrative expenses 3,361 2,759 6,288 5,569
Total operating expenses 8,927 7,656 18,234 15,536

Loss from operations (10,221 ) (7,925 ) (20,541 ) (15,598 )

Other (expense) income
Interest (expense) income (1,703 ) (1,102 ) (3,135 ) (2,096 )
Rental income — 55 — 109
Change in fair value of contingent real estate liability — (16 ) — (34 )
Change in fair value of derivative liabilities 14 (326 ) (184 ) (670 )
Total other (expense) income (1,689 ) (1,389 ) (3,319 ) (2,691 )
Net loss $ (11,910 ) $ (9,314 ) $ (23,860 ) $ (18,289 )

Net loss per common share - basic and diluted $ (0.30 ) $ (0.30 ) $ (0.61 ) $ (0.59 )

Weighted average common shares outstanding - basic and diluted 39,445,268 31,428,233 38,810,985 30,876,709

~~See accompanying notes to the condensed consolidated financial statements~~

A~~koustis Technologies, Inc.~~

~~Condensed Consolidated Statements of Changes in Stockholders’ Equity~~

~~(In thousands)~~

~~(Unaudited)~~

For the Six Months Ended December 31, 2020

Additional
Common Stock Paid In Accumulated Stockholders’
Shares Par Value Capital Deficit Equity

Balance, June 30, 2020 37,990 $ 38 $ 145,072 $ (103,615 ) $ 41,495

Common stock issued for services 127 — 2,027 — 2,027

Common stock issued for exercise of options 18 — 102 — 102

Common stock issued for cash, net of issuance costs 416 — 3,267 — 3,267

Common stock issued in payment of note interest 31 1 243 — 244

Net loss — — — (11,950 ) (11,950 )

Balance, September 30, 2020 38,582 $ 39 $ 150,711 $ (115,565 ) $ 35,185

Additional
Common Stock Paid In Accumulated Stockholders’
Shares Par Value Capital Deficit Equity

Balance, September 30, 2020 38,582 $ 39 $ 150,711 $ (115,565 ) $ 35,185

Common stock issued for cash, net of issuance costs 2,296 2 20,153 — 20,155

Common stock issued for services 350 — 2,066 — 2,066

Common stock issued for exercise of warrants 33 — 118 — 118

Common stock issued for exercise of options 73 — 422 — 422

ESPP purchase 32 — 204 — 204

Common stock issued in payment of note interest 33 — 244 — 244

Net loss — — — (11,910 ) (11,910 )

Balance, December 31, 2020 41,399 $ 41 $ 173,918 $ (127,475 ) $ 46,484

	For the Three Months Ended March 31, 2021			For the Three Months Ended March 31, 2020			For the Nine Months Ended March 31, 2021			For the Nine Months Ended March 31, 2020
Revenue
Revenue with customers	$	2,517		$	363		$	4,461		$	1,424

Cost of revenue		2,973			217			7,224			1,340

Gross profit (loss)		(456	)		146			(2,763	)		84

Operating expenses
Research and development		5,225			5,769			17,171			15,736
General and administrative expenses		3,395			2,589			9,683			8,158
Total operating expenses		8,620			8,358			26,854			23,894

Loss from operations		(9,076	)		(8,212	)		(29,617	)		(23,810	)

Other (expense) income
Interest (expense) income		(2,027	)		(1,162	)		(5,162	)		(3,259	)
Rental income		—			54			—			164
Change in fair value of contingent real estate liability		—			480			—			446
Change in fair value of derivative liabilities		928			1,066			744			396
Total other (expense) income		(1,099	)		438			(4,418	)		(2,253	)
Net loss	$	(10,175	)	$	(7,774	)	$	(34,035	)	$	(26,063	)

Net loss per common share - basic and diluted	$	(0.22	)	$	(0.21	)	$	(0.83	)	$	(0.80	)

Weighted average common shares outstanding - basic and diluted		45,620,610			36,236,779			41,047,723			32,659,339

See accompanying notes to the condensed consolidated financial statements.

Akoustis Technologies, Inc.

Condensed Consolidated Statements of Changes in Stockholders’ Equity

(In thousands)

(Unaudited)

	For the Six Months Ended December 31, 2019												For the Three Months Ended March 31, 2021
	Common Stock				Additional Paid In		Accumulated			Stockholders’							Additional
	Shares		Par Value		Capital		Deficit			Equity			Common Stock				Paid In		Accumulated			Stockholders’
													Shares		Par Value		Capital		Deficit			Equity
Balance, June 30, 2019		30,141	$	30	$	93,399	$	(67,474	)	$	25,955


Balance, December 31, 2020														41,399	$	41	$	173,918	$	(127,475	)	$	46,484

Common stock issued for cash, net of issuance costs														3,582		4		52,198		—			52,202
Common stock issued in note conversion														4,984		5		25,265		—			25,270
Common stock issued for services		283		—		1,703		—			1,703			96		—		1,991		—			1,991

Common stock issued for exercise of warrants		6		—		—		—			—			187		—		991		—			991

Vesting of restricted shares		—		—		303		—			303

Common stock issued for exercise of options														118		—		746		—			746
Common stock issued in payment of note interest		38		—		244		—			244			8		—		121		—			121

Net loss		—		—		—		(8,975	)		(8,975	)		—		—		—		(10,175	)		(10,175	)

Balance, September 30, 2019		30,468	$	30	$	95,649	$	(76,450	)	$	19,229
Balance, March 31, 2021														50,374		50		255,230		(137,650	)		117,630

	Common Stock					Additional Paid In		Accumulated			Stockholders’			For the Three Months Ended March 31, 2020
	Shares			Par Value		Capital		Deficit			Equity			Common Stock					Additional Paid In		Accumulated			Stockholders’
														Shares			Par Value		Capital		Deficit			Equity
Balance, September 30, 2019		30,468		$	30	$	95,649	$	(76,450	)	$	19,229


Balance, December 31, 2019															36,212		$	36	$	129,922	$	(85,764	)	$	44,194

Common stock issued for cash, net of issuance costs		5,520			6		32,164		—			32,170			—			—		19		—			19

Common stock issued for services		178			—		1,602		—			1,602			105			—		1,803		—			1,803

Common stock issued for exercise of warrants		68			—		—		—			—

Common stock issued for exercise of options		10			—		55		—			55			2			—		9		—			9

Common stock issued for equipment purchase		5			—		40		—			40

ESPP purchase		28			—		168		—			168

Common stock issued in payment of note interest		34			—		244		—			244			34			—		244		—			244

Repurchase and retirement of common shares		(99	)		—		—		—			—			(1	)		—		—		—			—

Net loss		—			—		—		(9,314	)		(9,314	)		—			—		—		(7,774	)		(7,774	)

Balance, December 31, 2019		36,212		$	36	$	129,922	$	(85,764	)	$	44,194
Balance, March 31, 2020															36,352			36		131,997		(93,538	)		38,495

See accompanying notes to the condensed consolidated financial statements.

Akoustis Technologies, Inc.

Condensed Consolidated Statements of Changes in Stockholders’ Equity

(In thousands)

(Unaudited)

	For the Nine Months Ended March 31, 2021
					Additional
	Common Stock				Paid In		Accumulated			Stockholders’
	Shares		Par Value		Capital		Deficit			Equity

Balance, June 30, 2020		37,990	$	38	$	145,072	$	(103,615	)	$	41,495

Common stock issued for cash, net of issuance costs		6,294		6		75,618		—			75,624
Common stock issued in note conversion		4,984		5		25,265		—			25,270
Common stock issued for services		574		1		6,083		—			6,084
Common stock issued for exercise of options		209		—		1,270		—			1,270
Common stock issued for exercise of warrants		219		—		1,109		—			1,109
ESPP purchase		32		—		204		—			204
Common stock issued in payment of note interest		72		—		609		—			609
Net loss		—		—		—		(34,035	)		(34,035	)

Balance, March 31, 2021		50,374	$	50	$	255,230	$	(137,650	)	$	117,630

	For the Nine Months Ended March 31, 2020
	Common Stock						Additional Paid In		Accumulated			Stockholders’
	Shares				Par Value		Capital		Deficit			Equity

Balance, June 30, 2019		30,141			$	30	$	93,399	$	(67,474	)	$25,955

Common stock issued for cash, net of issuance costs		5,520				6		32,184		—		32,190
Common stock issued for services		567				—		5,108		—		5,108
Common stock issued for exercise of options				12		—		64		—		64
Common stock issued for exercise of warrants		74				—		—		—		—
ESPP purchase				28		—		168		—		168
Common stock issued for equipment purchase		5				—		40		—		40
Vesting of restricted shares		—				—		303		—		303
Common stock issued in payment of note interest		106				—		731		—		731
Repurchase and retirement of common shares		(101	)			—		—		—		—
Net loss		—				—		—		(26,064	)	(26,064)

Balance, March 31, 2020		36,352			$	36	$	131,997	$	(93,538	)	$38,495

See accompanying notes to the condensed consolidated financial statements.

Akoustis Technologies, Inc.

Condensed Consolidated Statements of Cash Flows

(In thousands, except per share data)

(Unaudited)

Six Months
Ended
December 31,
2020 Six Months
Ended
December 31,
2019

CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss $ (23,860 ) $ (18,289 )
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization 2,080 1,419
Common stock issued for services 4,093 3,305
Amortization of debt discount 2,346 1,490
Amortization of operating lease right of use asset 110 55
Non cash interest payments 488 488
Change in fair value of derivative liabilities 184 670
Change in fair value of contingent real estate liability — 34
Changes in operating assets and liabilities:
Accounts receivable (395 ) (841 )
Inventory (515 ) —
Other current assets (443 ) 415
Other assets — (125 )
Accounts payable and accrued expenses (204 ) (663 )
Lease liabilities (111 ) (51 )
Deferred revenue 57 43
Net Cash Used in Operating Activities (16,170 ) (12,050 )

CASH FLOWS FROM INVESTING ACTIVITIES:
Cash paid for machinery and equipment (4,438 ) (4,171 )
Cash received from sale of fixed assets — 28
Cash paid for intangibles (53 ) (108 )
Net Cash Used in Investing Activities (4,491 ) (4,251 )

CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of common stock 23,192 32,277
Proceeds from exercise of employee stock options 524 55
Proceeds from exercise of warrants 118 —
Proceeds from employee stock purchase plan 204 168
Net Cash Provided by Financing Activities 24,038 32,500

Net Increase (Decrease) in Cash, Cash Equivalents and Restricted Cash 3,377 16,199

Cash, Cash Equivalents and Restricted Cash - Beginning of Period 44,408 30,154

Cash, Cash Equivalents and Restricted Cash - End of Period $ 47,785 $ 46,353

SUPPLEMENTARY CASH FLOW INFORMATION:
Cash Paid During the Period for:
Interest 325 325

SUPPLEMENTARY DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:

Common stock issued in payment of interest 488 488
Stock compensation payable — 303
Fixed assets included in accounts payable and accrued expenses 572 1,128
Stock issuance costs included in accounts payable and accrued expenses — 107
Reclass from assets held for sale — (251 )
Assets purchased using common stock — 40

	Nine Months Ended March 31, 2021			Nine Months Ended March 31, 2020
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$	(34,035	)		(26,063	)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization		3,284			2,194
Common stock issued for services		6,084			5,108
Amortization of debt discount		4,405			2,333
Amortization of operating lease right of use asset		168			91
Non cash interest payments		609			731
Change in fair value of derivative liabilities		(744	)		(396	)
Change in fair value of contingent real estate liability		—			(446	)
Changes in operating assets and liabilities:
Accounts receivable		(1,270	)		(407	)
Inventory		(1,310	)		18
Other current assets		(164	)		477
Other assets		—			(188	)
Accounts payable and accrued expenses		961			195
Lease liabilities		(170	)		(85	)
Deferred revenue		123			(5	)
Net Cash Used in Operating Activities		(22,059	)		(16,443	)

CASH FLOWS FROM INVESTING ACTIVITIES:
Cash paid for machinery and equipment		(9,884	)		(6,340	)
Cash received from sale of fixed assets		—			28
Cash paid for intangibles		(50	)		(143	)
Net Cash Used in Investing Activities		(9,934	)		(6,455	)

CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of common stock		75,394			32,189
Proceeds from exercise of employee stock options		1,270			64
Proceeds from exercise of warrants		1,109			—
Proceeds from employee stock purchase plan		204			168
Net Cash Provided by Financing Activities		77,977			32,421

Net Increase (Decrease) in Cash, Cash Equivalents and Restricted Cash		45,984			9,523
Cash, Cash Equivalents and Restricted Cash - Beginning of Period		44,408			30,154
Cash, Cash Equivalents and Restricted Cash - End of Period	$	90,392		$	39,677

SUPPLEMENTARY CASH FLOW INFORMATION:
Cash Paid During the Period for:
Interest		325			488

SUPPLEMENTARY DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:

Common stock issued in note conversion		(25,270	)		—
Stock compensation payable		—			303
Fixed assets included in accounts payable and accrued expenses		(1,467	)		290
Stock issuance costs included in accounts payable and accrued expenses		(230	)		—
Reclass from assets held for sale		—			(251	)
Assets purchased using common stock		—			40

See accompanying notes to the condensed consolidated financial statements

AKOUSTIS TECHNOLOGIES, INC.

Notes to the Condensed Consolidated Financial Statements ~~(Unaudited~~
(Unaudited))

Note 1. Organization

Akoustis Technologies, Inc. ~~(“the Company”~~(the “Company”) was incorporated on April 10, 2013, and effective December 15, 2016, the Company changed its state of incorporation to the State of Delaware. Through its subsidiary, Akoustis, Inc. (a Delaware corporation), the Company, headquartered in Huntersville, North Carolina, is focused on developing, designing, and manufacturing innovative radio frequency (“RF”) filter products for the wireless industry, including for products such as smartphones and tablets, cellular infrastructure equipment, WiFi Customer Premise Equipment (“CPE”), and military and defense communication applications. Located between the device’s antenna and its digital backend, the RF front-end (“RFFE”) is the circuitry that performs the analog signal processing and contains components such as amplifiers, filters and switches. To construct the resonator devices that are the building blocks for its RF filters, the Company has developed a family of novel, high purity acoustic piezoelectric materials as well as a unique microelectromechanical system (“MEMS”) wafer process, collectively referred to as ~~XBAW™~~XBAW^® technology. The Company leverages its integrated device manufacturing (“IDM”) business model to develop and sell high performance RF filters using its XBAWTM^® technology. Filters are critical in selecting and rejecting signals, and their performance enables differentiation in the modules defining the RFFE.

Note 2. Liquidity

As of ~~December~~March 31, ~~2020,~~2021, the Company had cash and cash equivalents of ~~$47.7~~$90.4 million and working capital of ~~$35.7~~$88.3 million. The Company has historically incurred recurring operating losses and experienced net cash used in operating activities.

As of ~~January 25,~~April 26, 2021, the Company had ~~$43.9~~$87.9 million of cash and cash equivalents, which the Company expects to be sufficient to fund its operations beyond the next twelve months from the date of filing of this Form 10-Q. These funds will be used to fund the Company’s operations, including capital expenditures, R&D, commercialization of our technology, development of our patent strategy and expansion of our patent portfolio, as well as to provide working capital and funds for other general corporate purposes. Except pursuant to its ATM Equity Offering^SM Sales Agreement with BofA Securities, Inc. and Piper Sandler & Co., the Company has no commitments or arrangements to obtain any additional funds, and there can be no assurance such funds ~~including under the ATM Equity Offering~~^SM ~~Sales Agreement,~~ will be available on acceptable terms or at all. If the Company is unable to obtain additional financing in a timely fashion and on acceptable terms, its financial condition and results of operations may be materially adversely affected and it may not be able to continue operations or execute its stated commercialization plan.

Note 3. Summary of Significant Accounting Policies

Basis of Presentation

The Company’s unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and the rules and regulations of the Securities and Exchange Commission (“SEC”) for interim financial information and the instructions to Form 10-Q. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for annual financial statements. In the opinion of management, all adjustments (consisting of normal accruals) considered necessary for a fair presentation have been included. The Company has evaluated subsequent events through the filing of this Form 10-Q. Operating results for the quarter ended ~~December~~March 31, ~~2020~~2021 are not necessarily indicative of the results that may be expected for the year ending June 30, 2021 or any future interim period. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and notes thereto included in the Company’s Form 10-K filed with the SEC on August 21, 2020 (the “2020 Annual Report”).

Principles of Consolidation

The accompanying unaudited condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiary, Akoustis, Inc. All significant intercompany accounts and transactions have been eliminated in consolidation.

Significant Accounting Policies and Estimates

The Company’s significant accounting policies are disclosed in Note 3-Summary of Significant Accounting Policies in the 2020 Annual Report. Since the date of the 2020 Annual Report, there have been no material changes to the Company’s significant accounting policies. The preparation of the unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the unaudited condensed consolidated financial statements and the accompanying notes thereto. The policies, estimates and assumptions include valuing equity securities and derivative financial instruments issued in financing transactions, deferred taxes and related valuation allowances, revenue recognition, contingent real estate liability and the fair values of long-lived assets. Actual results could differ from the estimates.

Allowance for Doubtful Accounts

The Company provides an allowance for doubtful accounts equal to the estimated losses to be incurred in the collection of accounts receivable.

Inventory

Inventory is stated at the lower of cost or net realizable value using the first-in, first-out (FIFO) valuation method.

Inventory consisted of the following as of ~~December~~March 31, ~~2020~~2021 and June 30, 2020 (in thousands):

December 31,
2020 June 30,
2020

Raw Materials $ 23 $ 24
Work in Process 464 69
Finished Goods 164 43
Total Inventory $ 651 $ 136

	March 31, 2021		June 30, 2020
Raw Materials	$	44	$	24
Work in Process		1,092		69
Finished Goods		310		43
Total Inventory	$	1,446	$	136

Shares of Restricted Stock Outstanding

Shares outstanding include shares of restricted stock with respect to which restrictions have not lapsed. Restricted stock included in reportable shares outstanding was the following as of ~~December~~March 31, ~~2020~~2021 and ~~2019.~~2020. Shares of restricted stock are included in the calculation of weighted average shares outstanding.

December 31, December 31,
2020 2019
Restricted stock included in reportable shares outstanding
10,000

144,750

		March 31, 2021				March 31, 2020
Restricted stock included in reportable shares outstanding			—				116,250

Reclassification

Certain prior period amounts have been reclassified to conform to current period presentation. The reclassifications did not have an impact on net loss as previously reported.

Recently Issued Accounting Pronouncements

Management does not believe that any recently issued, but not yet effective accounting pronouncements, when adopted, will have a material effect on the accompanying condensed consolidated financial statements.

Note 4. Revenue Recognition from Contracts with Customers

Disaggregation of Revenue

The Company’s primary revenue streams include foundry fabrication services and product sales.

Foundry Fabrication Services

Foundry fabrication services revenue includes Non-Recurring Engineering (“NRE”) and microelectromechanical systems (“MEMS”) foundry services. The Company exited the MEMS business during fiscal year 2020. Under these contracts, products are delivered to the customer at the completion of the service which represents satisfaction of the performance obligation as well as transfer of title. Depending on language with regards to enforceable right to payment for performance completed to date, related revenue will either be recognized over time or at a point in time.

Product Sales

Product sales revenue consists of sales of RF filters and amps which are sold with contract terms stating that title passes, and the customer takes control at the time of shipment. Revenue is then recognized when the devices are shipped, and the performance obligation has been satisfied. If devices are sold under contract terms that specify that the customer does not take ownership until the goods are received, revenue is recognized when the customer receives the goods.

The following table summarizes the revenues of the Company’s reportable segments for the three months ended ~~December~~March 31, ~~2020~~2021 (in thousands):

Foundry Fabrication Services Revenue Product Sales
Revenue Total
Revenue
with Customers
NRE - RF Filters $ 670 $ — $ 670
Filters/Amps — 638 638
Total $ 670 638 1,308

	Foundry Fabrication Services Revenue		Product Sales Revenue		Total Revenue with Customers
NRE - RF Filters	$	1,537	$	—	$	1,537
Filters/Amps		—		980		980
Total	$	1,537	$	980	$	2,517

The following table summarizes the revenues of the Company’s reportable segments for the ~~six~~nine months ended ~~December~~March 31, ~~2020~~2021 (in thousands):

	Foundry Fabrication Services Revenue		Product Sales Revenue		Total Revenue with Customers		Foundry Fabrication Services Revenue		Product Sales Revenue		Total Revenue with Customers
NRE - RF Filters		727		—		727	$	2,264	$	—	$	2,264
Filters/Amps		—		1,217		1,217		—		2,197		2,197
Total	$	727	$	1,217	$	1,944	$	2,264	$	2,197	$	4,461

The following table summarizes the revenues of the Company’s reportable segments for the three months ended ~~December~~March 31, ~~2019~~2020 (in thousands):

Foundry Fabrication
Services Revenue
Product Sales
Revenue Total
Revenue
with Customers
MEMS $ 12 $ — $ 12
NRE - RF Filters 311 — 311
Filters/Amps — 195 195
Total $ 323 $ 195 $ 518

	Foundry Fabrication Services Revenue		Product Sales Revenue		Total Revenue with Customers
MEMS	$	8	$	—	$	8
NRE - RF Filters		224		—		224
Filters/Amps		—		131		131
Total	$	232	$	131	$	363

The following table summarizes the revenues of the Company’s reportable segments for the ~~six~~nine months ended ~~December~~March 31, ~~2019~~2020 (in thousands):

	Foundry Fabrication Services Revenue		Product Sales Revenue		Total Revenue with Customers		Foundry Fabrication Services Revenue		Product Sales Revenue		Total Revenue with Customers
MEMS	$	257	$	—	$	257	$	265	$	—	$	265
NRE - RF Filters		427		—		427		652		—		652
Filters/Amps		—		377		377		—		507		507
Total	$	684	$	377	$	1,061	$	917	$	507	$	1,424

Performance Obligations

The Company has determined that contracts for product sales revenue and foundry fabrication services revenue involve one performance obligation, which is delivery of the final product.

Contract Balances

The following table summarizes the changes in the opening and closing balances of the Company’s contract asset and liability for the first ~~six~~nine months of fiscal ~~year~~years 2021 and 2020 ~~and 2019~~ (in thousands):

Contract
Assets

Contract
Liability

Balance, June 30, 2020 $ 125 $ —
Closing, December 31, 2020 383 57
Increase/(Decrease) $ 258 $ 57

Balance, June 30, 2019 $ 140 $ 5
Closing, December 31, 2019 139 13
Increase/(Decrease) $ (1 ) $ 8

	Contract Assets			Contract Liability
Balance, June 30, 2020	$	125		$	—
Closing, March 31, 2021		6			123
Increase/(Decrease)	$	(119	)	$	123

Balance, June 30, 2019	$	140		$	5
Closing, March 31, 2020		96			—
Increase/(Decrease)	$	(44	)	$	(5	)

The Company records a receivable when the title for goods has transferred. Generally, all sales are contract sales (with either an underlying contract or purchase order), resulting in all receivables being contract receivables. When invoicing occurs prior to revenue recognition a contract liability is recorded (as deferred revenue on the Condensed Consolidated Balance Sheets). ~~On December 31, 2020, the Company recorded a~~The contract liability balance as of ~~$57 thousand related to~~March 31, 2021 comprises various upfront payments for non-recurring engineering services that will be performed subsequent to ~~December~~March 31, ~~2020.~~2021. The amount of revenue recognized in the ~~six~~nine months ended ~~December~~March 31, ~~2019~~2020 that was included in the opening contract liability balance was $5 thousand which related to product sales.

Contract assets are recorded when revenue recognized exceeds the amount invoiced. The difference between the opening and closing balances of the Company’s contract assets and contract liabilities primarily results from the timing difference between the Company’s performance and the customer’s payment. The amount of contract assets invoiced in the ~~six~~nine months ended ~~December~~March 31, ~~2020~~2021 and ~~2019~~2020 that was included in the opening contract asset balance was ~~$54~~$119 thousand, which primarily related to non-recurring engineering services and ~~$198~~$96 thousand, which primarily related to non-recurring engineering services, respectively.

Backlog of Remaining Customer Performance Obligations

Revenue expected to be recognized and recorded as sales during this fiscal year from the backlog of performance obligations that are unsatisfied (or partially unsatisfied) was ~~$3.8~~$2.8 million at ~~December~~March 31, ~~2020.~~2021.

Note 5. Property and Equipment, net

Property and equipment, net consisted of the following as of ~~December~~March 31, ~~2020~~2021 and June 30, 2020 (in thousands):

	Estimated Useful Life	December 31, 2020			June 30, 2020			Estimated Useful Life	March 31, 2021			June 30, 2020
Land	n/a	$	1,000		$	1,000		n/a	$	1,000		$	1,000
Building	11 years		3,000			3,000		11 years		3,000			3,000
Equipment	2-10 years		27,689			24,746		2-10 years		32,098			24,746
Leasehold Improvements	*		1,550			964		*		1,815			964
Software	3 years		294			294		3 years		479			294
Furniture & Fixtures	5 years		11			11		5 years		11			11
Computer Equipment	3 years		281			267		3 years		286			267
Total			33,825			30,282				38,689			30,282
Less: Accumulated Depreciation			(8,745	)		(6,677	)			(9,934	)		(6,677	)
Total		$	25,080		$	23,605			$	28,755		$	23,605

(*)

Leasehold improvements are amortized on a straight-line basis over the term of the lease or the estimated useful lives, whichever is shorter.

The Company recorded depreciation expense of ~~$1.1~~$1.2 million and $0.7 million for the three months ended ~~December~~March 31, ~~2020~~2021 and ~~2019,~~2020, respectively. The Company recorded depreciation expense of ~~$2.1~~$3.3 million and ~~$1.4~~$2.2 million for the ~~six~~nine months ended ~~December~~March 31, ~~2020~~2021 and ~~2019,~~2020, respectively.

As of ~~December~~March 31, ~~2020,~~2021, equipment with a net book value totaling ~~$3.8~~$7.0 million had not been placed in service and therefore was not depreciated during the period. As of June 30, 2020, fixed assets with a net book value totaling $5.6 million had not been placed in service and therefore was not depreciated during the period.

Note 6. Accounts Payable and Accrued Expenses

Accounts payable and accrued expenses consisted of the following at ~~December~~March 31, ~~2020~~2021 and June 30, 2020 (in thousands):

December 31,
2020

June 30,
2020

Accounts payable $ 936 $ 2,135
Accrued salaries and benefits 2,336 2,478
Accrued professional fees 95 193
Accrued utilities 228 138
Accrued interest 146 137
Accrued goods received not invoiced 792 396
Other accrued expenses 37 422
Totals $ 4,570 $ 5,899

	March 31, 2021		June 30, 2020
Accounts payable	$	897	$	2,135
Accrued salaries and benefits		3,502		2,478
Accrued professional fees		98		193
Accrued utilities		128		138
Accrued interest		14		137
Accrued goods received not invoiced		434		396
Other accrued expenses		90		422
Totals	$	5,163	$	5,899

Note 7. Derivative Liabilities

The table below provides a summary of the changes in fair value, including net transfers in and/or out, of all financial assets and liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) during the ~~six~~nine months ended ~~December~~March 31, ~~2020~~2021 (in thousands):

	Fair Value Measurement Using Level 3 Inputs Total		Fair Value Measurement Using Level 3 Inputs Total
Balance, June 30, 2020	$	1,110	$	1,110
Change in fair value of derivative liabilities		184		(1,110	)
Balance, December 31, 2020 (see note 8)	$	1,294
Balance, March 31, 2021 (see note 8)			$	—

The fair value of the derivative features of the ~~convertible note~~October 2018 Notes and the May 2018 Notes (as defined in Note 8 below) at the balance sheet dates were calculated using the with-and-without method, a form of the income approach, valued with the following assumptions:

December 31,
2020

June 30,
2020

Remaining term (years) 2.41 2.92-3.42
Expected volatility 68 % 70 %
Risk free interest rate 0.15 % 0.18-0.20 %
Dividend yield 0.00 % 0.00 %

	June 30, 2020
Remaining term (years)		2.92-3.42
Expected volatility		70	%
Risk free interest rate		0.18-0.20	%
Dividend yield		0.00	%

Risk-free interest rate: The Company uses the risk-free interest rate of a U.S. Treasury Bill with a similar term on the date of the issuance.

Dividend yield: The Company uses a 0% expected dividend yield as the Company has not paid dividends to date and does not anticipate declaring dividends in the near future.

Volatility: The Company calculates the expected volatility of the stock price using the historical volatilities of the Company’s common stock traded on the Nasdaq Capital Market.

Remaining term: The Company’s remaining term is based on the remaining contractual term of the convertible notes.

Note 8. Convertible Notes

On December 4, 2020, the Company provided a notice of redemption to the holders of the Company’s outstanding $10,000,000 aggregate principal amount of 6.5% Convertible Senior Notes due 2023 (CUSIP No: 00973N AC6) (the “October 2018 Notes”) regarding the Company’s exercise of its option to redeem all October 2018 Notes on February 1, 2021 (the ~~“Redemption~~“October Redemption Date”), unless earlier converted as described below, pursuant to the indenture governing the October 2018 Notes. Pursuant to the notice of redemption, the Company would pay holders of the October 2018 Notes that are redeemed a redemption price equal to 100% of the aggregate principal amount of October 2018 Notes being redeemed, plus accrued and unpaid interest as well as an interest make-whole payment with respect to those October 2018 Notes that are redeemed.

All of the holders of the October 2018 Notes elected to convert the October 2018 Notes into shares of common stock of the Company prior to the October Redemption Date at a conversion rate equal to 196.08 shares of common stock per $1,000 principal amount of Notes (equivalent to a conversion price of approximately $5.10 per share). ~~See Note 16. Subsequent Events.~~

During the quarter ended March 31, 2021, the Company converted approximately $10.0 million of principal into approximately 1.96 million shares of the Company’s common stock. The ~~following table summarizes convertible~~Company also recognized $96 thousand of unamortized debt discount as a reduction to equity.

On January 25, 2021, the Company provided a notice of ~~December 31, 2020 (in thousands):~~redemption to the holders of the Company’s outstanding $15,000,000 aggregate principal amount of 6.5% Convertible Senior Secured Notes due 2023 (CUSIP No: 00973N AA0) (the “May 2018 Notes”) regarding the Company’s exercise of its option to redeem all Notes on March 1, 2021 (the “May Redemption Date”), unless earlier converted as described below, pursuant to the indenture governing the Notes. Pursuant to the notice of redemption, the Company would pay holders of the Notes that are redeemed a redemption price equal to 100% of the aggregate principal amount of Notes being redeemed, plus accrued and unpaid interest.

Stated Remaining Fair Value
of
Embedded
Interest Conversion Face Debt Conversion Carrying
Maturity Date Rate Price Value (Discount) Option Value
Short Term convertible notes payable
6.5% convertible senior notes 02/01/2021 6.50 % $ 5.10 $ 10,000 (205 ) — 9,795
Ending Balance as of December 31, 2020 $ 10,000 $ (205 ) $ — $ 9,795

Long Term convertible notes payable
6.5% convertible senior notes 5/31/2023 6.50 % $ 5.00 $ 15,000 (1,943 ) 1,294 14,351
Ending Balance as of December 31, 2020 $ 15,000 $ (1,943 ) $ 1,294 $ 14,351

All of the holders of the May 2018 Notes elected to convert the May 2018 Notes into shares of common stock of the Company prior to the May Redemption Date at a conversion rate equal to 200 shares of common stock per $1,000 principal amount of notes (equivalent to a conversion price of $5.00 per share). The holders of the May 2018 Notes also received an interest make-whole payment at a weighted average rate of 1.52 shares per $1,000 principal amount of notes with respect to those May 2018 Notes that were converted.

During the quarter ended March 31, 2021, the Company converted approximately $15.0 million of principal and $366 thousand of make whole payment liability into approximately 3.02 million shares of the Company’s common stock. The Company also recognized $477 thousand of unamortized debt discount as additional interest expense during the conversion.

The following table summarizes convertible debt as of June 30, 2020 (in thousands):

		Stated							Remaining			Fair Value of Embedded
		Interest			Conversion		Face		Debt			Conversion		Carrying
	Maturity Date	Rate			Price		Value		(Discount)			Option		Value		Maturity Date		Stated Interest Rate			Conversion Price		Face Value		Remaining Debt (Discount)			Fair Value of Embedded Conversion Option		Carrying Value
Long Term convertible notes payable
6.5% convertible senior secured notes	5/31/2023		6.50	%	$	5.00	$	15,000	$	(3,918	)	$	894	$	11,976		5/31/2023		6.50	%	$	5.00	$	15,000	$	(3,918	)	$	894	$	11,976
6.5% convertible senior notes	11/30/2023		6.50	%	$	5.10		10,000		(564	)		216		9,652		11/30/2023		6.50	%		5.10		10,000		(564	)		216		9,652

Ending Balance as of June 30, 2020							$	25,000	$	(4,482	)	$	1,110	$	21,628								$	25,000	$	(4,482	)	$	1,110	$	21,628

Note 9. Loans Payable

~~Paycheck Protection Program Loan~~Promissory Note

On May 20, 2020, Akoustis, Inc., the operating subsidiary of the Company, issued a promissory note (the “Promissory Note”) in favor of Bank of America, NA (the “Lender”) that ~~provides~~provided for a loan in the principal amount of $1.6 million ~~(the “PPP Loan”)~~ pursuant to the Paycheck Protection Program (the “PPP”) under the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”)~~, which is administered by the United States Small Business Administration (the “SBA”)~~. The ~~PPP Loan is scheduled to mature two years from the date of funding of the PPP Loan (the “Maturity Date”) and accrues~~Promissory Note accrued interest at a rate of 1.00% per annum. On November 20, 2020, Akoustis, Inc. applied to the Lender for forgiveness of the full amount of the PPP Loan. Such forgiveness will be determined, subject to limitations, based on the use of loan proceeds in accordance with the PPP, including for payroll costs and mortgage interest, rent and utility costs. If the SBA confirms full forgiveness of the unpaid balance of the PPP Loan, and reimburses the Lender for the total outstanding principal and interest due under the PPP Loan, then the loan will be deemed satisfied in full. If the SBA does not confirm full forgiveness of the PPP Loan, then the Lender will establish repayment terms of the outstanding principal and interest due under the PPP Loan. Payments under the PPP Loan are deferred to the date that the SBA remits the PPP Loan forgiveness amount. No assurance is provided that Akoustis, Inc. will obtain forgiveness of the PPP Loan in whole or in part. The Promissory Note contains customary events of default relating to, among other things, payment defaults and provisions of the Promissory Note. The Company treated the ~~PPP Loan~~Promissory Note as debt and included the future monthly repayment amounts payable within 12 months as a short-term liability and the remainder of the ~~PPP loan~~Promissory Note debt as a long-term liability on the balance sheet. As described in Note 16 below, the Promissory Note was forgiven pursuant to the PPP on April 9, 2021.

The following table summarizes ~~Paycheck Protection Program~~the Promissory Note debt as of ~~December~~March 31, ~~2020~~2021 (in thousands):

	Maturity Date	Stated Interest Rate			Face Value		Remaining Debt (Discount)			Carrying Value
Short Term Loans payable
Promissory Note	10/31/2021 - 12/31/2021		1.00	%	$	1,240	$	(22	)	$	1.218
Ending Balance as of March 31, 2021					$	1,240	$	(22	)	$	1,218

Long Term Loans payable
Promissory Note	05/20/2022		1.00	%	$	393	$	(1	)	$	392
Ending Balance as of March 31, 2021					$	393	$	(1	)	$	392

Stated Remaining
Interest Face Debt Carrying
Maturity Date Rate Value (Discount) Value
Short Term Loans payable
Paycheck Protection Program loan 10/31/2021- 12/31/2021 1.00 % $ 619 $ (25 ) $ 594

Ending Balance as of December 31, 2020 $ 619 $ (29 ) $ 594
Long Term Loans payable

Paycheck Protection Program loan 05/20/2022 1.00 % $ 1,014 $ (4 ) $ 1,010

Ending Balance as of December 31, 2020 $ 1,014 $ (4 ) $ 1,010

The following table summarizes ~~Paycheck Protection Program~~the Promissory Note debt as of June 30, 2020 (in thousands):

Maturity Date
Stated
Interest
Rate
Face
Value Remaining
Debt
(Discount) Carrying
Value
Long Term Loans payable
Paycheck Protection Plan loan 05/20/2022 1.00 % $ 1,633 $ (42 ) $ 1,591

Ending Balance as of June 30, 2020 $ 1,633 $ (42 ) $ 1,591

	Maturity Date	Stated Interest Rate			Face Value		Remaining Debt (Discount)			Carrying Value
Long Term Loans payable
Promissory Note	05/20/2022		1.00	%	$	1,633	$	(42	)	$	1,591
Ending Balance as of June 30, 2020					$	1,633	$	(42	)	$	1,591

The amortization of ~~PPP loan~~the Promissory Note debt discount of ~~$6.4~~$6.3 thousand and ~~$12.8~~$19.1 thousand for the three month and ~~six~~nine month ~~period~~periods ending ~~December~~March 31, ~~2020,~~2021, respectively, was treated as interest expense on the statement of operations.

Note 10. Concentrations

Vendors

Vendor concentration as a percentage of purchases for the three months ended ~~December~~March 31, ~~2020~~2021 and ~~2019~~2020 are as follows:

	Three Months ~~12/~~03/31/~~2020~~2021			Three Months ~~12/~~03/31/~~2019~~2020
Vendor 1		1318	%		—
~~Vendor 2~~		—			19	%
~~Vendor 3~~		—			12	%

Vendor concentration as a percentage of purchases for the ~~six~~nine months ended ~~December~~March 31, ~~2020~~2021 and ~~2019~~2020 are as follows:

	~~Six~~Nine Months ~~12/~~03/31/~~2020~~2021		~~Six~~Nine Months ~~12/~~03/31/~~2019~~2020
Vendor 1		—		1813	%

Customers

Customer concentration as a percentage of revenue for the three months ended ~~December~~March 31, ~~2020~~2021 and ~~2019~~2020 are as follows:

Three Months
12/31/2020 Three Months
12/31/2019
Customer 1 18 % —
Customer 2 29 % —
Customer 3 32 % 55 %
Customer 4 15 % 29 %

	Three Months 03/31/2021			Three Months 03/31/2020
Customer 1		57	%		—
Customer 2		34	%		—
Customer 3		—			38	%
Customer 4		—			33	%
Customer 5		—			12	%
Customer 6		—			11	%

Customer concentration as a percentage of revenue for the ~~six~~nine months ended ~~December~~March 31, ~~2020~~2021 and ~~2019~~2020 are as follows:

	Six Months 12/31/2020			Six Months 12/31/2019			Nine Months 03/31/2021			Nine Months 03/31/2020
Customer 1		22	%		30	%		43	%		22	%
Customer 2		—			23	%		38	%		—
Customer 3		—			14	%		—			20	%
Customer 4		—			13	%		—			11	%
Customer 5		—			10	%		—			13	%
Customer 6		10	%		—			—			17	%
Customer 7		44	%		—
Customer 8		12	%		—

Note 11. Stockholders’ Equity

~~ATM~~Equity Offering Program ~~and Offerings~~

On May 8, 2020, the Company entered into an ATM Equity Offering^SM Sales Agreement with BofA Securities, Inc. and Piper & Sandler & Co. (the “Sales Agreement”) pursuant to which the Company may sell from ~~time to time~~time-to-time shares of its common stock having an aggregate offering price of up to $50,000,000 (the ~~“ATM~~“Equity Offering Program”). On February 22, 2021, the Company entered into Amendment No. 1 to the Sales Agreement , which increased the amount of shares of common stock the Company may sell from time-to-time under the Equity Offering Program by an incremental $50,000,000.

Three months ended	Avg price per share		Number of Shares		Gross Proceeds (in millions)		Offering Expenses (in millions)		Net Proceeds (in millions)
September 30, 2020	$	8.09		416,221	$	3.4	$	0.1	$	3.3
December 31, 2020	$	8.93		2,296,023	$	20.5	$	0.4	$	20.1
March 31, 2021	$	14.99		2,082,148	$	31.2	$	0.5	$	30.7
Total	$	11.49		4,794,392	$	55.1	$	1.0	$	54.1

February 2021 Registered Direct Offering

~~During the three months ended September 30, 2020,~~On February 19, 2021, the Company ~~sold~~entered into securities purchase agreements to sell a total of ~~416,221~~1,500,000 shares of its common stock to a limited number of institutional investors in a registered direct offering at a purchase price ~~to the public~~ of ~~an average of $8.09~~$14.3592 per share ~~through the ATM Program~~ for aggregate gross proceeds of ~~approximately $3.4 million, before deducting compensation paid~~$21.5 million. The offering closed on February 23, 2021. The Company expects to use the ~~sales agents~~proceeds of the offering to fund the Company’s operations and growth of its business, including for capital expenditures, working capital, research and development, the commercialization of its technology and other ~~offering expenses payable by the company of approximately $0.1 million.~~general corporate purposes.

During the three months ended December 31, 2020, the Company sold a total of 2,296,023 shares of its common stock at a price to the public of an average of $8.93 per share through the ATM Program for aggregate gross proceeds of approximately $20.5 million, before deducting compensation paid to the sales agents and other offering expenses payable by the company of approximately $0.4 million.

Equity Incentive Plans

During the ~~six~~nine months ended ~~December~~March 31, ~~2020,~~2021, the Company granted employees options to purchase an aggregate of ~~415,554~~approximately 0.5 million shares of common stock with a weighted average grant date fair value of ~~$4.46.~~$5.05 per share. The fair values of the Company’s options were estimated at the dates of grant using a Black-Scholes option pricing model with the following assumptions:

	~~Six~~Nine Months Ended ~~December~~March 31, ~~2020~~2021
Exercise price		$ 7.72 ~~- 8.54~~– 17.61
Expected term (years)		4.00 – 5.00
Risk-free interest rate		0.25% – ~~0.42~~%0.78%
Volatility		67 -– 68%
Dividend yield		0%
Weighted Average Grant Date Fair Value of Options granted during the period		$ ~~4.46~~5.05

During the ~~six~~nine months ended ~~December~~March 31, ~~2020~~2021 the Company awarded certain employees and directors grants of an aggregate of ~~634,061~~approximately 0.8 million restricted stock units (“RSUs”) with a weighted average grant date fair value of ~~$8.25.~~$9.74. The RSUs will be expensed over the requisite service period. The terms of the RSUs include vesting provisions based solely on continued service. If the service criteria are satisfied, the RSUs will generally vest over 4 – 5 years.

Compensation expense related to our stock-based awards described above was as follows (in thousands):

	Three Months Ended December 31,				Six Months Ended December 31,				Three Months Ended March 31,				Nine Months Ended March 31,
	2020		2019		2020		2019		2021		2020		2021		2020
Research and Development	$	928	$	790	$	1,942	$	1,746	$	1,011	$	929	$	2,953	$	2,675
General and Administrative		1,138		812		2,151		1,559		980		874		3,131		2,433
Total	$	2,066	$	1,602	$	4,093	$	3,305	$	1,991	$	1,803	$	6,084	$	5,108

Unrecognized stock-based compensation expense and weighted-average years to be recognized are as follows (in thousands):

	As of December 31, 2020				As of March 31, 2021
	Unrecognized stock-based compensation		Weighted- average years to be recognized		Unrecognized stock-based compensation		Weighted- average years to be recognized
Options	$	2,887		2.24	$	2,820		2.21
Restricted stock awards/units	$	8,443		2.27	$	9,064		2.29

Note 12. Commitments and Contingencies

Leases

The Company leases office space and office equipment in Huntersville, NC as well as equipment in Canandaigua, NY. Our leases have remaining lease terms of up to five years, some of which include options to extend the leases for up to twenty-four months. Following adoption of ASC 842, lease expense excludes capital area maintenance and property taxes.

The components of lease expense were as follows:

Three
Months Ended
December 31,
2020 Three
Months Ended
December 31,
2019
Six
Months Ended
December 31,
2020

Six
Months Ended
December 31,
2019

Operating Lease Expense $ 75 $ 46 $ 150 $ 102

Three
Months Ended
March 31,
2021

Three
Months Ended
March 31,
2020

Nine

Months Ended
March 31,
2021

Nine

Months Ended
March 31,
2020

Operating Lease Expense

225

144

Supplemental balance sheet information related to leases was as follows (in thousands):

	Classification on the Condensed Consolidated Balance Sheet	December 31, 2020			Classification on the Condensed Consolidated Balance Sheet	March 31, 2021
Assets
Operating lease assets	Other non-current assets	$	589		Other non-current assets	$	531

Liabilities
Other current liabilities	Current liabilities		250		Current liabilities		260
Operating lease liabilities	Other non-current liabilities		342		Other non-current liabilities		274

Weighted Average Remaining Lease Term:
Operating leases			2.25				2.01

Weighted Average Discount Rate:
Weighted Average Discount Rate:
Operating leases			12.47	%			12.47	%

The following table outlines the minimum future lease payments for the next five years and thereafter, (in thousands):

For the year ending June 30,
2021	$	154		$	78
2022		312			312
2023		204			204
2024		7			7
2025		—			—
Thereafter		—			—
Total lease payments (undiscounted cash flows)		677			601

Less imputed interest		(85	)		(67	)
Total	$	592		$	534

Ontario County Industrial Development Authority Agreement

On February 27, 2018, the Company entered into a Lease and Project Agreement (the “Lease and Project Agreement”) and a Company Lease Agreement (the “Company Lease Agreement” and together with the Lease and Project Agreement, the “Agreements”), each dated as of February 1, 2018, with the Ontario County Industrial Development Agency, a public benefit corporation of the State of New York (the “OCIDA”). Pursuant to the Agreements, the Company ~~will lease~~leases for $1.00 annually to the OCIDA an approximately 9.995 acre parcel of land in Canandaigua, New York, together with the improvements thereon (including the Company’s New York fabrication facility), and transfer title to certain related equipment and personal property to the OCIDA (collectively, the “Facility”). The OCIDA ~~will lease~~leases the Facility back to the Company for annual rent payments specified in the Lease and Project Agreement for the Company’s primary use as research and development, manufacturing, warehouse and professional office space in its business, and to be subleased, in part, by the Company to various existing tenants. The Company estimates substantial tax savings during the term of the Agreements, which expire on December 31, 2028. In addition, subject to the terms of the Lease and Project Agreement, certain purchases and leases of eligible items will be exempt from the imposition of sales and use taxes. Subject to the terms of the Lease and Project Agreement, the OCIDA has also granted to the Company an exemption from certain mortgage recording taxes for one or more mortgages securing an aggregate principal amount not to exceed $12.0 million, or such greater amount as approved by the OCIDA in its sole and absolute discretion. The benefits provided to the Company pursuant to the terms of the Lease and Project Agreement are subject to claw back over the life of the Agreements upon certain recapture events, including certain events of default.

Litigation, Claims and Assessments

From time to time, the Company may become involved in lawsuits, investigations and claims that arise in the ordinary course of business. The Company believes it has meritorious defenses against all pending claims and intends to vigorously pursue them. While it is not possible to predict or determine the outcomes of any pending actions, the Company believes the amount of liability, if any, with respect to such actions, would not materially affect its financial position, results of operations or cash flows.

Note 13. Related Party Transactions

Asset Purchase and Sale

On September 30, 2020, Akoustis, Inc. sold to a third party certain of its inventory, together with related warranty obligations, delivery commitments and design data and files (the “Designs”)~~. In connection with such~~ for $215,000. This transaction was enabled by the purchase by Akoustis, Inc. ~~entered into~~under an Asset Purchase Agreement dated September 30, 2020 with Big Red, LLC ~~for the purchase~~ of the Designs for $25,000. Members of Big Red, LLC include the brother of the Company’s Chief Executive Officer and two non-executive employees of the Company.

Note 14. Segment Information

Operating segments are defined as components of an enterprise about which separate financial information is available and evaluated regularly by the chief operating decision maker, or decision–making group, in deciding how to allocate resources and in assessing performance. The Company’s chief operating decision maker is its Chief Executive Officer. The Company operates in two segments, Foundry Fabrication Services, which consists of engineering review services and STC-MEMS foundry services, and RF Product, which consists of amplifier and filter product sales, and grant revenue. The Company records all general and administrative costs in the RF Product segment.

The Company evaluates performance of its operating segments based on revenue and operating profit (loss). Segment information for the three and ~~six~~nine months ended ~~December~~March 31, ~~2020~~2021 and ~~2019~~2020 are as follows (in thousands):

	Foundry/ Fabrication Services		RF Product			Total			Foundry/ Fabrication Services		RF Product			Total

Three months ended December 31, 2020
Three months ended March 31, 2021
Revenue with customers	$	670	$	638		$	1,308		$	1,537	$	980		$	2,517
Cost of revenue		350		2,252			2,602			400		2,573			2,973
Gross margin		320		(1,614	)		(1,294	)		1,137		(1,593	)		(456	)
Research and development		—		5,566			5,566			—		5,225			5,225
General and administrative		—		3,361			3,361			—		3,395			3,395
Income (Loss) from Operations	$	320		(10,567	)		(10,221	)	$	1,137	$	(10,213	)	$	(9,076	)

Three months ended December 31, 2019
Three months ended March 31, 2020
Revenue with customers	$	323	$	195		$	518		$	232	$	131		$	363
Cost of revenue		270		517			787			138		79			217
Gross margin		53		(322	)		(269	)		94		52			146
Research and development		—		4,897			4,897			—		5,769			5,769
General and administrative		—		2,759			2,759			—		2,589			2,589
Income (Loss) from Operations	$	53		(7,978	)		(7,925	)	$	94	$	(8,306	)	$	(8,212	)

Six months ended December 31, 2020
Nine months ended March 31, 2021
Revenue with customers	$	727	$	1,217		$	1,944		$	2,264	$	2,197		$	4,461
Cost of revenue		403		3,848			4,251			803		6,421			7,224
Gross margin		324		(2,631	)		(2,307	)		1,461		(4,224	)		(2,763	)
Research and development		—		11,946			11,946			—		17,171			17,171
General and administrative		—		6,288			6,288			—		9,683			9,683
Income (Loss) from Operations	$	324		(20,865	)		(20,541	)	$	1,461	$	(31,078	)	$	(29,617	)

Six months ended December 31, 2019
Nine months ended March 31, 2020
Revenue with customers	$	684	$	377		$	1,061		$	917	$	507		$	1,424
Cost of revenue		407		716			1,123			545		795			1,340
Gross margin		277		(339	)		(62	)		372		(288	)		84
Research and development		—		9,967			9,967			—		15,736			15,736
General and administrative		—		5,569			5,569			—		8,158			8,158
Income (Loss) from Operations	$	277		(15,875	)		(15,598	)	$	372	$	(24,182	)	$	(23,810	)

As of December 31, 2020
As of March 31, 2021
Accounts receivable	$	488	$	258		$	746		$	1,498	$	122		$	1,620
Property and equipment, net		—	$	25,080		$	25,080			—	$	28,755		$	28,755

As of June 30, 2020
Accounts receivable	$	71	$	280		$	351		$	71	$	280		$	351
Property and equipment, net	$	—	$	23,605		$	23,605		$	—	$	23,605		$	23,605

Note 15. Loss Per Share

Basic net loss per common share is computed by dividing net loss attributable to common stockholders by the weighted-average number of common shares outstanding during the period. Diluted net loss per common share is determined using the weighted-average number of common shares outstanding during the period, adjusted for the dilutive effect of common stock equivalents. In periods when losses are reported, which is the case for the ~~six~~nine months ended ~~December~~March 31, ~~2020~~2021 and ~~December~~March 31, ~~2019~~2020 presented in these condensed consolidated financial statements, the weighted-average number of common shares outstanding excludes common stock equivalents because their inclusion would be anti-dilutive.

The Company had the following common stock equivalents at ~~December~~March 31, ~~2020~~2021 and ~~2019:~~2020:

	December 31,		December 31,
	2020		2019		March 31, 2021		March 31, 2020
Convertible Notes		4,960,800		4,960,800		—		4,960,800
Options		2,589,719		2,242,665		2,484,477		2,265,165
Warrants		359,570		541,999		167,809		541,999
Total		7,910,089		7,745,464		2,652,286		7,767,964

Note. 16. Subsequent Events

~~October 2018 Note Conversion~~

On ~~January 7,~~April 9, 2021, Akoustis, Inc. received notice from the ~~Company issued 980,400 shares of its common stock upon~~Lender that the ~~conversion of $5.0 million principal~~full amount of ~~October 2018 Notes.~~

~~On January 26, 2021,~~ the ~~Company issued 980,400 shares of its common stock upon the conversion of the remaining $5.0 million principal amount of October 2018 Notes.~~

~~Redemption of May 2018 Notes~~

On January 25, 2021, the Company provided a notice of redemption to the holders of the Company’s outstanding $15,000,000 aggregate principal amount of 6.5% Convertible Senior Secured Notes due 2023 (CUSIP No: 00973N AA0) (the “May 2018 Notes”) regarding the Company’s exercise of its option to redeem all May 2018 Notes on March 1, 2021, unless earlier converted as described below,Promissory Note was forgiven pursuant to the indenture governing the May 2018 Notes. The Company will pay holders of the May 2018 Notes that are redeemed a redemption price equal to 100% of the aggregate principal amount of October 2018 Notes being redeemed, plus accrued and unpaid interest with respect to those October 2018 Notes that are redeemed.

Alternatively, holders of the May 2018 Notes may elect to convert the May 2018 Notes into shares of common stock of the Company at a conversion rate equal to 200 shares of common stock per $1,000 principal amount of May 2018 Notes (equivalent to a conversion price of $5.00 per share) and an interest-make whole payment.PPP Loan.

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

References in this report to “Akoustis,” the “Company,” “we,” “us,” and “our” refer to Akoustis Technologies, Inc. and its consolidated subsidiary, Akoustis, Inc., each of which is a Delaware corporation.

Cautionary Note Regarding Forward-Looking Statements

This quarterly report on Form 10-Q contains forward-looking statements that relate to our plans, objectives, estimates, and goals. Any and all statements contained in this report that are not statements of historical fact may be deemed to be forward-looking statements. Terms such as “may,” “might,” “would,” “should,” “could,” “project,” “estimate,” “predict,” “potential,” “strategy,” “anticipate,” “attempt,” “develop,” “plan,” “help,” “believe,” “continue,” “intend,” “expect,” “future,” and terms of similar import (including the negative of any of the foregoing) may identify forward-looking statements. However, not all forward-looking statements may contain one or more of these identifying terms. Forward-looking statements in this report may include, without limitation, statements regarding (i) the plans and objectives of management for future operations, including plans or objectives relating to the development of commercially viable radio frequency (“RF”) filters, (ii) projections of income (including income/loss), earnings (including earnings/loss) per share, capital expenditures, dividends, capital structure or other financial items, (iii) our future financial performance, including any such statement contained in this management’s discussion and analysis of financial condition or in the results of operations included pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”), (iv) our ability to efficiently utilize cash and cash equivalents to support our operations for a given period of time, (v) our ability to engage customers while maintaining ownership of our intellectual property, and (vi) the assumptions underlying or relating to any statement described in (i), (ii), (iii), (iv) or (v) above.

Forward-looking statements are not meant to predict or guarantee actual results, performance, events or circumstances and may not be realized because they are based upon our current projections, plans, objectives, beliefs, expectations, estimates, and assumptions and are subject to a number of risks and uncertainties and other influences, many of which are beyond our control. Actual results and the timing of certain events and circumstances may differ materially from those described by the forward-looking statements as a result of these risks and uncertainties. Factors that may influence or contribute to the inaccuracy of the forward-looking statements or cause actual results to differ materially from expected or desired results may include, without limitation, our inability to obtain adequate financing and sustain our status as a going concern; our limited operating history; our inability to ~~service the debt represented by our $15.0 million principal amount of convertible senior secured notes due 2023 (called for redemption in March 2021); our inability to~~ generate revenues or achieve profitability; the results of our research and development (“R&D”) activities; our inability to achieve acceptance of our products in the market; the impact of the COVID-19 pandemic on our operations, financial condition and the worldwide economy, including its impact on our ability to access the capital markets; general economic conditions, including upturns and downturns in the industry; shortages in supplies needed to manufacture our products, or needed by our customers to manufacture devices incorporating our products; our limited number of patents; failure to obtain, maintain, and enforce our intellectual property rights; our inability to attract and retain qualified personnel; our reliance on third parties to complete certain processes in connection with the manufacture of our products; product quality and defects; existing or increased competition; our ability to market and sell our products; our inability to successfully scale our New York wafer fabrication facility and related operations while maintaining quality control and assurance and avoiding delays in output; contracting with customers and other parties with greater bargaining power and agreeing to terms and conditions that may adversely affect our business; risks related to doing business in foreign countries; any security breaches or other disruptions compromising our proprietary information and exposing us to liability; our failure to innovate or adapt to new or emerging technologies; our failure to comply with regulatory requirements; results of any arbitration or litigation that may arise; stock volatility and illiquidity; our failure to implement our business plans or strategies; and our failure to maintain effective internal control over financial ~~reporting; and our failure to obtain and maintain the Trusted Foundry accreditation of our New York wafer fabrication facility.~~reporting.

These and other risks and uncertainties, which are described in more detail in our Annual Report on Form 10-K, filed with the SEC on August 21, 2020 (the “2020 Annual Report”), could cause our actual results to differ materially from those expressed or implied by the forward-looking statements in this report. Readers are cautioned not to place undue reliance on forward-looking statements because of the risks and uncertainties related to them. Except as may be required by law, we do not undertake any obligation to update the forward-looking statements contained in this report to reflect any new information or future events or circumstances or otherwise.

Overview

Akoustis® is an emerging commercial product company focused on developing, designing, and manufacturing innovative RF filter solutions for the wireless industry, including for products such as smartphones and tablets, network infrastructure equipment, WiFi Customer Premise Equipment (“CPE”) and defense applications. Filters are critical in selecting and rejecting signals, and their performance enables differentiation in the modules defining the RF front-end (“RFFE”). Located between the device’s antenna and its digital backend, the RFFE is the circuitry that performs the analog signal processing and contains components such as amplifiers, filters and switches. We have developed a proprietary microelectromechanical system (“MEMS”) based bulk acoustic wave (“BAW”) technology and a unique manufacturing process flow, called ~~“XBAW”~~“XBAW^®”, for our filters produced for use in RFFE modules. Our XBAW^®filters incorporate optimized high purity piezoelectric materials for high power, high frequency and wide bandwidth operation. We are developing RF filters for ~~4G/LTE,~~ 5G, WiFi and defense bands using our proprietary resonator device models and product design kits (PDKs). As we qualify our RF filter products, we are engaging with target customers to evaluate our filter solutions. Our initial designs target UHB, sub 7 GHz ~~4G/LTE,~~ 5G, WiFi and defense bands. We expect our filter solutions will address problems (such as loss, bandwidth, power handling, and isolation) created by the growing number of frequency bands in the RFFE of mobile devices, infrastructure and premise equipment to support ~~4G/LTE,~~ 5G, and WiFi. We have prototyped, sampled and begun commercial shipment of our single-band ~~low-~~low loss BAW filter designs for ~~4G/LTE frequency bands,~~ 5G frequency bands and ~~5GHz~~5 GHz and 6 GHz WiFi bands which are suited to competitive BAW solutions and historically cannot be addressed with low-band, lower power handling surface acoustic wave (“SAW”) technology.

We own and/or have filed applications for patents on the core resonator device technology, manufacturing facility and intellectual property (“IP”) necessary to produce our RF filter chips and operate as a “pure-play” RF filter supplier, providing discrete filter solutions direct to Original Equipment Manufacturers (“OEMs”) and aligning with the front- end module manufacturers that seek to acquire high performance filters to expand their module businesses. We believe this business model is the most direct and efficient means of delivering our solutions to the market.

Technology. Our device technology is based upon bulk-mode acoustic resonance, which we believe is superior to surface-mode resonance for high-band and ultra-high- band (“UHB”) applications that include 4G/LTE, 5G, WiFi, and defense applications. Although some of our target customers utilize or manufacture the RFFE module, they may lack access to critical UHB filter technology that we produce, which is necessary to compete in high frequency applications.

Manufacturing. We currently manufacture our high-performance RF filter circuits, using our first generation ~~XBAWTM~~XBAW^® wafer process, in our 120,000-square foot wafer- manufacturing facility located in Canandaigua, New York (the “NY Facility”), which we acquired in June 2017.

Intellectual Property. As of ~~January~~April 19, 2021, our IP portfolio included 3846 patents, including a blocking patent that we have licensed from Cornell University. Additionally, as of ~~January~~April 19, 2021, we have 7579 pending patent applications. These patents cover our XBAW TM^® RF filter technology from raw materials through the system architectures.

By designing, manufacturing, and marketing our RF filter products to mobile phone OEMs, defense OEMs, network infrastructure OEMs, and WiFi CPE OEMs, we seek to enable broader competition among the front-end module manufacturers.

Since we own and/or have filed applications for patents on the core technology and control access to our intellectual property, we expect to offer several ways to engage with potential customers. First, we intend to engage with multiple wireless markets, providing standardized filters that we design and offer as standard catalog components. Second, we expect to deliver unique filters to customer-supplied specifications, which we will design and fabricate on a customized basis. Finally, we may offer our models and design kits for our customers to design their own filters utilizing our proprietary technology.

We have earned minimal revenue from operations since inception, and we have funded our operations primarily with development contracts, RF filter and production orders, government grants, ~~MEMS~~ foundry and engineering services, and sales of debt and equity securities. The Company has incurred losses, primarily the result of material and processing costs associated with developing and commercializing our technology, as well as personnel costs, professional fees (primarily accounting and legal), and other general and administrative (“G&A”) expenses. We expect to continue to incur substantial costs for commercialization of our technology on a continuous basis because our business model involves materials and solid-state device technology development and engineering of catalog and custom filter design solutions.

To succeed, we must convince mobile phone OEMs, RFFE module manufacturers, network infrastructure OEMs, WiFi CPE OEMs and defense customers to use our XBAW^®filter technology in their systems and modules. However, since there are two dominant BAW filter suppliers in the industry that have high-band technology, and both utilize such technology as a competitive advantage at the module level, we expect customers that lack access to high-band filter technology will be open to engage with our pure-play filter company.

We plan to pursue RF filter design and R&D development agreements and potentially joint ventures with target customers and other strategic partners, although we cannot guarantee we will be successful in these efforts. These types of arrangements may subsidize technology development costs and qualification, filter design costs, and offer complementary technology and market intelligence and other avenues to revenue. However, we intend to retain ownership of our core technology, intellectual property, designs, and related improvements. We expect to pursue development of catalog designs for multiple customers and to offer such catalog products in multiple sales channels.

Impact of COVID-19 on our Business

Although the ultimate impact of the COVID-19 pandemic on our business is unknown, in an effort to protect the health and safety of our employees, we have taken proactive, precautionary action and adopted social distancing measures, daily self-health attestations, and mandatory mask policies at our locations, including when warranted by state and local guidelines, the implementation of new staffing plans in our facilities whereby certain employees work remotely and the remaining on-site force is divided into multiple shifts or segregated in different parts of the facility. Our actions continue to evolve in response to new government measures and scientific knowledge regarding COVID-19. In an effort to contain COVID-19 or slow its spread, governments around the world have also enacted various measures, including orders to close all businesses not deemed “essential,” isolate residents to their homes or places of residence, and practice social distancing when engaging in essential activities. These measures have impacted the method and timing of certain business meetings and deliverables to certain customers, as well as our ability to obtain certain materials, equipment and services from suppliers. For example, Executive Orders issued by the Governor of New York introduced potential delays in the procurement of installation and maintenance services from vendors without personnel located in New York, New Jersey or Connecticut.

These actions and the global health crisis caused by COVID-19 have negatively impacted business activity across the globe. We have observed declining demand and price reductions in the electronics industry as business and consumer activity has decelerated. Additionally, we have observed delays in certain suppliers’ shipment of materials necessary for us to manufacture our products and in certain vendors’ ability to deliver equipment for installation at our facilities. When COVID-19 is demonstrably contained, we anticipate a rebound in economic activity, depending on the rate, pace, and effectiveness of the containment efforts deployed by various national, state, and local governments; however, the timing and extent of any such rebound is uncertain.

We will continue to actively monitor the situation and may take further actions altering our business operations that we determine are in the best interests of our employees, customers, partners, suppliers, and stakeholders, or as required by federal, state, or local authorities. It is not clear what the ultimate effects any such alterations or modifications may have on our business, including the effects on our customers, employees, and prospects, or on our financial results for the remainder of fiscal year 2021 or beyond.

Recent Developments

On ~~October 13, 2020, the Company announced it shipped its fourth 5G small cell network infrastructure filter to a tier-1 infrastructure customer, operating in the 5G new radio band n79.~~

~~On October 27, 2020, the Company announced it was awarded a new DARPA contract to advance XBAW® technology through a direct-to-phase 2 (DP2) program.~~

~~On October 29, 2020,~~January 26, 2021, Akoustis ~~announced that it received an order from a Citizen’s Broadband Radio Service (CBRS) equipment OEM for both network and consumer premise equipment XBAW® filter solutions.~~

~~On November 2, 2020, the Company announced it received an order from a leading RF front end maker for the development of 5G/WiFi mobile coexistence filters.~~

~~On December 7, 2020, Akoustis announced that it~~ issued a redemption notice ~~with respect to $10~~on the remaining $15 million principal amount of the Company’s outstanding 6.5% convertible senior secured notes due in 2023.

On ~~December 9, 2020,~~January 27, 2021, the Company announced that it had achieved design-lock on its 5.5 GHz and 6.5 GHz WiFi 6E coexistence filter modules.

On January 29^th, 2021, Akoustis announced that it had received a volume order from a tier-1 customer for its 5.5 GHz and 6.5 GHz WiFi 6E coexistence filter modules.

On February 1, 2021, the Company announced that it had locked the process flow for its first wafer-level-chip-scale-package for XBAW^® filters.

On March 3, 2021, the Company announced that it had been awarded a new design win for XBAW^® filters from a Citizens Broadband Radio Service (CBRS) customer.

On March 8, 2021, Akoustis announced the discharge of the indentures associated with the $15 million 6.5% convertible senior secured notes due 2023.

On March 29, 2021, the Company announced it ~~was awarded~~had secured a WiFi 6E reference design ~~win for its 5.2/5.6 GHz~~with a tier-1 WiFi ~~6 coexistence filters for a new customer. The XBAW® filters will be used for a tri-band gateway/router using a multi-user, multiple-in, multiple-out (MU-MIMO) architecture.~~system-on-chip (SoC) maker.

~~On December 14, 2020, Akoustis announced it was awarded a third WiFi 6 design win for a tri-band MU-MIMO bridge product.~~

~~On December 16, 2020, the Company announced it received an order for new 5G mobile XBAW® filters from a tier-1 RF front-end maker for smartphones and other devices.~~

Critical Accounting Policies

There have been no material changes to our critical accounting policies and estimates from the information provided in Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” included in our 2020 Annual Report.

Results of Operations

Three Months Ended ~~December~~March 31, ~~2020~~2021 and ~~2019~~2020

Revenue

The Company recorded revenue of ~~$1.3~~$2.5 million for the three months ended ~~December~~March 31, ~~2020~~2021 as compared to ~~$0.5~~$0.4 million for the three months ended ~~December~~March 31, ~~2019.~~2020. The increase of ~~$0.8~~$2.1 million was primarily due to an increase in non-recurring engineering services of $1.3 million or 584% as well as an increase in RF product revenue of ~~$0.4~~$0.9 million, or ~~227%. In addition, non-recurring engineering services increased by $0.4 million or 115%~~1,742%.

Cost of Revenue

Cost of revenue includes direct labor, material, net realizable value (NRV) adjustments, and facility costs primarily associated with foundry services revenue, manufacturing of filter products and engineering services. The Company recorded cost of revenue of ~~$2.6~~$3.0 million for the three months ended ~~December~~March 31, ~~2020~~2021 as compared to ~~$0.8~~$0.2 million for the three months ended ~~December~~March 31, ~~2019.~~2020. The ~~$1.8~~$2.8 million increase is primarily due to costs associated with RF product revenue which increased by ~~$0.5~~$2.5 million ~~as well as cost of goods sold associated with net realizable value (NRV) inventory adjustments totaling $1.2~~in addition to non-recurring engineering costs which increased by $0.3 million.

Research and Development Expenses

R&D expenses were $5.2 million for the three months ended ~~December~~March 31, ~~2020.~~

~~Research and Development Expenses~~

~~R&D expenses were $5.6 million for the three months ended December 31, 2020~~2021 and were ~~$0.7~~$0.6 million, or ~~13.7% higher~~9.4% lower than the prior year amount for the same period of ~~$4.9~~$5.8 million. ~~The period-over-period increase was primarily in the areas of R&D personnel costs, R&D materials and facility costs as well as R&D equipment depreciation.~~ Personnel costs, including stock-based compensation, were ~~$2.9~~$3.1 million compared to ~~$2.7~~$3.4 million in the prior year period, ~~an increase~~a decrease of ~~$0.2~~$0.3 million or ~~8.5%~~8.9%. ~~The higher personnel cost was primarily due to increased headcount at both the Huntersville, NC location and the NY Facility. Material and facility~~Facility costs of $1.9 million primarily associated with the NY Facility were ~~$0.7~~$0.3 million ~~higher~~lower than the prior period. ~~Repairs and maintenance and general expenses were lower than~~These decreases are a result of a shift from R&D activities to production activities when compared to the prior ~~period by $0.1 million.~~period.

General and Administrative Expense

General and administrative (“G&A”) expenses include salaries and wages for executive and administrative staff, stock-based compensation, professional fees, insurance costs and other general costs associated with the administration of our business. G&A expenses for the three months ended ~~December~~March 31, ~~2020~~2021 were $3.4 million, which is an increase of ~~$0.6~~$0.8 million compared to the three months ended ~~December~~March 31, ~~2019. Year over year~~2020. Year-over-year changes within G&A expenses include an increase in employee compensation (including stock-based compensation) of ~~$0.6~~$0.4 million ~~which was partially offset by lower~~as well as increased general expenses of $0.3 million, primarily professional fees.

Other (Expense)/Income

Other expenses for the three months ended ~~December~~March 31, ~~2020~~2021 were ~~$1.7~~($1.1) million, which included debt discount amortization of ~~$1.3~~$2.1 million. Offsetting this expense was a gain on derivative liability valuation of $0.9 million ~~and interest expense, net~~related to the conversion of ~~$0.4 million.~~notes payable. Other ~~expenses~~income for the three months ended ~~December~~March 31, ~~2019~~2020 were ~~$1.4~~$0.4 million, consisting of $0.8 million of debt discount amortization and interest expense, net of $0.3 million, a gain on derivative liability valuation of $1.1 million and a ~~change in fair value of our derivative~~gain on contingent liability of ~~$0.3~~$0.5 million.

Net Loss

The Company recorded a net loss of ~~$11.9~~$10.2 million for the three months ended ~~December~~March 31, ~~2020,~~2021, compared to a net loss of ~~$9.3~~$7.8 million for the three months ended ~~December~~March 31, ~~2019.~~2020. The period-over-period incremental loss of ~~$2.6~~$2.4 million, or ~~28%~~31%, was primarily driven by an increase in cost of revenue, ~~R&D expenses~~ and ~~general and administrative~~G&A expenses of ~~$3.1~~$3.0 million as well as an increase in debt discount amortization of $1.2 million. These expense increases were partially offset by a revenue increase of ~~$0.8~~$2.1 million.

~~Six Months~~Nine months Ended ~~December~~March 31, ~~2020~~2021 and ~~2019~~2020

Revenue

The Company recorded revenue of ~~$1.9~~$4.5 million for the ~~six~~nine months ended ~~December~~March 31, ~~2020~~2021 as compared to ~~$1.1~~$1.4 million for the ~~six~~nine months ended ~~December~~March 31, ~~2019.~~2020. The increase of ~~$0.8~~$3.1 million was primarily due to an increase in RF product revenue of ~~$0.8~~$1.6 million, or ~~223%~~386%. In addition, non-recurring engineering services increased by ~~$0.3~~$1.6 million, or ~~70%~~247%. Partially offsetting these increases was a decrease in MEMS revenue of $0.3 million, a product line that the Company exited during fiscal year 2020.

Cost of Revenue

Cost of revenue includes direct labor, material, net realizable value (NRV) adjustments, and facility costs primarily associated with foundry services revenue, manufacturing of filter products and engineering services. The Company recorded cost of revenue of ~~$4.3~~$7.2 million for the ~~six~~nine months ended ~~December~~March 31, ~~2020~~2021 as compared to ~~$1.1~~$1.3 million for the ~~six~~nine months ended ~~December~~March 31, ~~2019.~~2020. The ~~$3.1~~$5.9 million increase is primarily due to costs associated with the production of RF ~~product revenue~~products, which increased by ~~$2.0~~$5.6 million as well as cost ~~of goods sold associated with net realizable value (NRV) inventory adjustments totaling $1.1~~related to non-recurring engineering services which increased by $0.3 million for the ~~six~~nine months ended ~~December~~March 31, ~~2020.~~2021.

Research and Development Expenses

R&D expenses were ~~$11.9~~$17.2 million for the ~~six~~nine months ended ~~December~~March 31, ~~2020~~2021 and were ~~$2.0~~$1.4 million, or ~~20%~~9.1%, higher than the prior year amount for the same period of ~~$10.0~~$15.7 million. The period-over-period increase was primarily in the areas of R&D personnel costs, R&D materials and facility costs as well as R&D equipment depreciation. Personnel costs, including stock-based compensation, were ~~$6.4~~$9.6 million compared to ~~$5.7~~$9.2 million in the prior year period, an increase of ~~$0.7~~$0.4 million or ~~12.5%~~4.5%. The higher personnel cost was primarily due to increased headcount at both the Huntersville, NC location and the NY Facility. Material and facility costs of ~~$3.6~~$7.0 million primarily associated with the NY Facility were ~~$1.2~~$1.0 million higher than the comparative ~~period due to increased R&D activities.~~period.

General and Administrative Expense

~~General and administrative (“~~G~~&A”)~~&A expenses include salaries and wages for executive and administrative staff, stock-based compensation, professional fees, insurance costs and other general costs associated with the administration of our business. G&A expenses for the ~~six~~nine months ended ~~December~~March 31, ~~2020~~2021 were ~~$6.3~~$9.7 million, which is an increase of ~~$0.7~~$1.5 million compared to the ~~six~~nine months ended ~~December~~March 31, ~~2019.~~2020. Year over year changes within G&A expenses include ~~an increase~~increases in employee compensation (including stock-based compensation) of ~~$0.8~~$1.2 million ~~which was~~and sales and marketing expenses of $0.2 million. These increases were partially offset by lower general expenses, primarily professional fees, as well as a reduction in severance expense.

Other (Expense)/Income

Other expenses for the ~~six~~nine months ended ~~December~~March 31, ~~2020~~2021 were ~~$3.3~~($4.4) million, which included debt discount amortization of ~~$2.3~~$4.4 million, interest expense, net of $0.8 million, and a ~~change in~~gain on fair value of ~~our~~ derivative liability of ~~$0.2~~$0.7 million. Other expenses for the ~~six~~nine months ended ~~December~~March 31, ~~2019~~2020 were ~~$2.7~~($2.3) million, consisting of ~~$1.5~~$2.3 million of debt discount amortization and interest expense, net of ~~$0.6~~$0.9 million ~~and a change in~~as well as gains on fair value of ~~our~~ derivative liability and contingent liability of ~~$0.7 million.~~$0.4 million and $0.4 million, respectively.

Net Loss

The Company recorded a net loss of ~~$23.9~~$34.0 million for the ~~six~~nine months ended ~~December~~March 31, ~~2020,~~2021, compared to a net loss of ~~$18.3~~$26.0 million for the ~~six~~nine months ended ~~December~~March 31, ~~2019.~~2020. The period-over-period incremental loss of ~~$5.6~~$8.0 million, or 31%, was primarily driven by an increase in cost of revenue, ~~and~~ R&D expenses and general and administrative expenses of ~~$5.1~~$8.8 million. In addition, interest expense, including debt discount amortization, increased by $1.9 million. These expense increases were partially offset by an increase in revenue of $3.0 million as well as a gain on the fair value of derivative liability of $0.3 million.

Liquidity and Capital Resources

Financing Activities

During the three months ended March 31, 2021, the Company sold a total of 2,082,148 shares of its common stock at a price to the public of an average of $14.99 per share under the Sales Agreement for aggregate gross proceeds of approximately $31.2 million, before deducting compensation paid to the sales agents and other offering expenses of approximately $0.5 million. As of March 31, 2021, the Company had sold common stock for aggregate gross proceeds of $55.1 million under the Sales Agreement.

On February 19, 2021, the Company entered into a securities purchase agreement with a limited number of institutional investors for the registered direct offering of an aggregate of 1,500,000 shares of common stock at a purchase price of $14.3592 per share (the “Registered Direct Offering”). The Registered Direct Offering closed on February 23, 2021 and resulted in gross proceeds of approximately $21.5 million.

Balance Sheet and Working Capital

The Company had ~~$47.7~~$90.4 million of cash and cash equivalents on hand as of ~~December~~March 31, ~~2020,~~2021, which reflects an increase of ~~$3.4~~$46.0 million compared to $44.3 million as of June 30, 2020. The increase is primarily due to cash proceeds from common stock issuance of ~~$23.2~~$75.4 million which was partially offset by ~~$16.2~~$22.1 million in net cash used in operating activities and ~~$4.5~~$9.9 million in capital expenditures for the ~~six~~nine months ended ~~December~~March 31, ~~2020.~~2021. The Company estimates that cash on hand will be sufficient to fund its operations, including current capital expense commitments, beyond the next twelve months from the date of filing of this Form 10-Q. However, the Company has historically incurred recurring operating losses and will continue to do so until it generates sufficient revenues from operations; as a result, we may need to obtain additional capital through the sale of additional equity securities, debt, or otherwise, to fund operations past that date. There is no assurance that the Company’s projections and estimates are accurate. The Company is actively managing and controlling the Company’s cash outflows to mitigate liquidity risks.

~~Balance Sheet and Working Capital~~

~~December~~March 31, ~~2020~~2021 compared to June 30, 2020

As of ~~December~~March 31, ~~2020,~~2021, the Company had current assets of ~~$50.9~~$95.0 million made up primarily of cash on hand of ~~$47.7~~$90.4 million. As of June 30, 2020, current assets were $46.2 million comprised primarily of cash on hand of $44.3 million.

Property, Plant and Equipment was ~~$25.1~~$28.8 million as of ~~December~~March 31, ~~2020~~2021 as compared to a balance of $23.6 million as of June 30, 2020.

Total assets as of ~~December~~March 31, ~~2020~~2021 and June 30, 2020 were ~~$77.6~~$125.2 million and $71.4 million, respectively.

Current liabilities as of ~~December~~March 31, ~~2020~~2021 and June 30, 2020 were ~~$15.3~~$6.8 million and $6.1 million, respectively. The increase of ~~$9.2~~$0.7 million was due to the reclassification of a portion of our loans payable ~~and convertible debt~~ from long term liabilities to current liabilities offset by a decrease in accounts payable and accrued expenses.

Long-term liabilities totaled ~~$15.8~~$0.8 million as of ~~December~~March 31, ~~2020,~~2021, compared to $23.8 million as of June 30, 2020. The decrease of ~~$8.0~~$23.0 million was due to the ~~reclassification~~conversion of ~~a portion of our loans~~notes payable ~~and convertible debt from long term liabilities to current liabilities offset by debt discount amortization related to our convertible notes.~~during the reporting period.

Stockholders’ equity was ~~$46.5~~$117.6 million as of ~~December~~March 31, ~~2020,~~2021, compared to $41.5 million as of June 30, 2020, an increase of ~~$5.0~~$76.1 million, or ~~12%~~183%. This increase was primarily due to the increase in additional paid-in-capital (“APIC”) of ~~$28.8~~$110.2 million for the ~~six~~nine months ended ~~December~~March 31, ~~2020~~2021 which was partially offset by the net loss for the ~~six~~nine months ended ~~December~~March 31, ~~2020~~2021 of ~~$23.9~~$34.0 million. The increase in APIC was primarily due to common stock issued for cash and the conversion of ~~$23.4~~notes payable of $100.5 million, common stock issued for services of ~~$4.1~~$6.1 million and stock options exercised of ~~$0.5~~$1.3 million.

Cash Flow Analysis

Operating activities used cash of ~~$16.2~~$22.1 million during the ~~six~~nine months ended ~~December~~March 31, ~~2020~~2021 and ~~$12.1~~$16.4 million during the ~~2019~~ comparative ~~period.~~period ended March 31, 2020. The ~~$4.1~~$5.6 million period- over-period increase in cash used was attributable to higher operating expenses associated with the ramp of development and commercialization activities (primarily R&D and production personnel and material costs).

Investing activities used cash of ~~$4.5~~$9.9 million for the ~~six~~nine months ended ~~December~~March 31, ~~2020~~2021 compared to ~~$4.3~~$6.5 million for the comparative period ended ~~December~~March 31, ~~2019.~~2020. The ~~$0.2~~$3.4 million period-over-period increase was primarily due to increased purchases of production equipment.

Financing activities increased cash by ~~$24.0~~$78.0 million during the ~~six~~nine months ended ~~December~~March 31, ~~2020~~2021 compared to the ~~same~~comparative period ~~in 2019 primarily~~ended March 31, 2020 due to proceeds from issuance of common stock pursuant to the ~~Company’s ATM Equity Offering~~^SMSales Agreement ~~with BofA Securities, Inc. and Piper& Sandler & Co.~~as well as proceeds from the Registered Direct Offering. In addition, stock option grants, warrant exercises and proceeds from our employee stock purchase plan (“ESPP”) resulted in cash proceeds of ~~$0.8~~$2.6 million.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

Not applicable to smaller reporting companies.

ITEM 4. CONTROLS AND PROCEDURES

Management’s Evaluation of Disclosure Controls and Procedures

We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in the reports that we file or submit under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) is (1) recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms and (2) accumulated and communicated to our management, including our principal executive officer and principal financial officer, to allow timely decisions regarding required disclosure.

As of ~~December~~March 31, ~~2020,~~2021, our management, with the participation of our Chief Executive Officer and Interim Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act). Our management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives, and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Our Chief Executive Officer and Interim Chief Financial Officer have concluded based upon the evaluation described above that, as of ~~December~~March 31, ~~2020,~~2021, our disclosure controls and procedures were effective at the reasonable assurance level.

Changes in Internal Control over Financial Reporting

During the quarter ended ~~December~~March 31, ~~2020,~~2021, there were no changes in our internal control over financial reporting, as such term is defined in Rules 13a-15(f) and 15(d)-15(f) promulgated under the Securities Exchange Act of 1934, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II - OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS.

From time to time, we may become involved in various lawsuits and legal proceedings that arise in the ordinary course of business. Litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may have an adverse effect on our business, financial condition or results of operations and prospects.

We are currently not aware of any material pending legal proceedings to which we are a party or of which any of our property is the subject, nor are we aware of any such proceedings that are contemplated by any governmental authority.

ITEM 1A. RISK FACTORS.

In addition to the risk factors set forth below and the other information set forth in this report, you should carefully consider the factors discussed under Part I, Item 1A, “Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended June 30, 2020. These factors could materially adversely affect our business, financial condition, liquidity, results of operations and capital position, and could cause our actual results to differ materially from our historical results or the results contemplated by the forward-looking statements contained in this report. ~~There~~Other than as follows, there have been no material changes to the risk factors described in Part I, Item 1A, “Risk Factors,” included in our 2020 Annual Report.

Our common stock has been thinly traded and its share price in the public markets has experienced, and may in the future experience, extreme volatility.

Our common stock has traded on the Nasdaq Capital Market, under the symbol “AKTS,” since March 13, 2017. Since that date, our common stock has been relatively thinly traded and at times been subject to price volatility. Recently, from December 1, 2020 to March 31, 2021, the closing price of our common stock on the Nasdaq Capital Market ranged from $7.52 to $18.58 per share. Between December 1, 2020 and March 31, 2021, the intra-day sales price of our common stock fluctuated between a reported low sale price of $7.40 and a reported high sales price of $19.15.

The stock market and development-stage public companies in particular have been subject to extreme price and volume fluctuations that have often been unrelated or disproportionate to the operating performance of such companies. Additionally, technical factors in the public trading market for our stock may produce price movements that may or may not comport with macro, industry or company-specific fundamentals, including, without limitation, the sentiment of retail investors (including as may be expressed on financial trading and other social media sites), speculation in the press, in the investment community, or on the internet, including on online forums and social media, about our Company, our industry or our securities, the amount and status of short interest in our securities (including a “short squeeze”), access to margin debt, trading in options and other derivatives on our common stock and other technical trading factors. We may incur rapid and substantial decreases in our stock price in the foreseeable future that are unrelated to our operating performance or prospects. There can be no guarantee that our stock price will remain at current prices or that future sales of our common stock will not be at prices lower than the sales price in this offering.

The daily trading volume of our common stock has historically been relatively low. If we are unable to develop and maintain a liquid market for our common stock, you may not be able to sell your common stock at prices you consider to be fair or at times that are convenient for you, or at all. This situation may be attributable to a number of factors, including but not limited to the fact that we are a development-stage company that is relatively unknown to stock analysts, stock brokers, institutional investors, and others in the investor community. In addition, investors may be risk averse to investments in development-stage companies. The low trading volume is outside of our control and may not increase or, if it increases, may not be maintained. In addition, following periods of volatility in the market price of a company’s securities, litigation has often been brought against that company and we may become the target of litigation as a result of price volatility. Litigation could result in substantial costs and divert our management’s attention and resources from our business. This could have a material adverse effect on our business, results of operations and financial condition.

We depend on a few large customers for a substantial portion of our revenue.

A substantial portion of our revenue comes from large purchases by a small number of customers. Our future operating results depend on both the success of our largest customers and on our success in diversifying our products and customer base.

The concentration of our revenue with a relatively small number of customers makes us particularly dependent on factors, both positive and negative, affecting those customers. If demand for their devices incorporating our products increases, our results are favorably impacted, while if demand for their devices decreases, they may reduce their purchases of, or stop purchasing, our products and our operating results would suffer. Even if we achieve a design win, our customers can delay, temporarily suspend, or cancel the manufacture or release of a new device for any reason, such as a shortage of supply of other components needed to manufacture their device. Most of our customers can cease incorporating our products into their devices with little notice to us and with little or no penalty. The loss of a large customer and failure to add new customers to replace lost revenue would have a material adverse effect on our business, financial condition and results of operations.

Global shortages in manufacturing capacities could negatively affect our operations and negatively impact our results of operations.

Our business depends in significant part upon manufacturers of products requiring semiconductors, as well as the current and anticipated production of these products. As a supplier to such manufacturers, we are subject to the business cycles that characterize the industry. Recent sharp increases in demand for semiconductor products have resulted in a global shortage of manufacturing capacities and it is unclear how long this shortage may last. If our customers are forced to reduce the amount of their products they manufacture or plan to manufacture due to a limited supply of semiconductors, our business, financial condition and results of operations could be negatively affected.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

Unregistered Sales of Equity Securities

Other than any sales previously reported in the Company’s Current Reports on Form 8-K, the Company did not sell any unregistered securities during the period covered by this report.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES.

Not applicable.

ITEM 4. MINE SAFETY DISCLOSURES.

Not applicable.

ITEM 5. OTHER INFORMATION.

Not applicable.

ITEM 6. EXHIBITS.

The exhibits in the Exhibit Index below are filed or furnished, as applicable, as part of this report.

EXHIBIT INDEX

Exhibit Number		Description

3.1		Articles of Conversion of the Company, as filed with the Nevada Secretary of State on December 15, 2016 (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed with the SEC on December 16, 2016)

3.2		Certificate of Conversion of the Company, as filed with the Delaware Secretary of State on December 15, 2016 (incorporated by reference to Exhibit 3.2 to the Company’s Current Report on Form 8-K filed with the SEC on December 16, 2016)

3.3		Certificate of Incorporation, as filed with the Delaware Secretary of State on December 15, 2016 (incorporated by reference to Exhibit 3.3 to the Company’s Current Report on Form 8-K filed with the SEC on December 16, 2016)

3.4		Amended and Restated Bylaws of the Company (incorporated by reference to Exhibit 3.5 to the Company’s Quarterly Report on Form 10-Q filed with the SEC on May 1, 2020)
10.1*†		Akoustis Technologies, Inc. Director Compensation Program, effective August 28, 2020

10.2		Form of Securities Purchase Agreement, dated February 19, 2021, by and among the Company and the Purchasers party thereto (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on From 8-K filed with the SEC on February 22, 2021)

31.1*		Rule 13(a)-14(a)/15(d)-14(a) Certification of Principal Executive Officer

31.2*		Rule 13(a)-14(a)/15(d)-14(a) Certification of Principal Financial Officer

32.1*		Section 1350 Certification of Principal Executive Officer

32.2*		Section 1350 Certification of Principal Financial Officer

101*		Interactive Data Files of Financial Statements and Notes

101.INS*		Instant Document

101.SCH*		XBRL Taxonomy Schema Document

101.CAL*		XBRL Taxonomy Calculation Linkbase Document

101.DEF*		XBRL Taxonomy Definition Linkbase Document

101.LAB*		XBRL Taxonomy Label Linkbase Document

101.PRE*		XBRL Taxonomy Presentation Linkbase Document

*	Filed herewith

†

Management contract or compensatory plan or arrangement

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Dated: ~~February 1,~~May 3, 2021	Akoustis Technologies, Inc.

	By:	/s/ Kenneth E. Boller
		Kenneth E. Boller
		Interim Chief Financial Officer
		(Principal Financial and Accounting Officer)

	For the Three Months Ended December 31, 2020			For the Three Months Ended December 31, 2019			For the Six Months Ended December 31, 2020			For the Six Months Ended December 31, 2019
Revenue
Revenue with customers	$	1,308		$	518		$	1,944		$	1,061

Cost of revenue		2,602			787			4,251			1,123

Gross profit (loss)		(1,294	)		(269	)		(2,307	)		(62	)

Operating expenses
Research and development		5,566			4,897			11,946			9,967
General and administrative expenses		3,361			2,759			6,288			5,569
Total operating expenses		8,927			7,656			18,234			15,536

Loss from operations		(10,221	)		(7,925	)		(20,541	)		(15,598	)

Other (expense) income
Interest (expense) income		(1,703	)		(1,102	)		(3,135	)		(2,096	)
Rental income		—			55			—			109
Change in fair value of contingent real estate liability		—			(16	)		—			(34	)
Change in fair value of derivative liabilities		14			(326	)		(184	)		(670	)
Total other (expense) income		(1,689	)		(1,389	)		(3,319	)		(2,691	)
Net loss	$	(11,910	)	$	(9,314	)	$	(23,860	)	$	(18,289	)

Net loss per common share - basic and diluted	$	(0.30	)	$	(0.30	)	$	(0.61	)	$	(0.59	)

Weighted average common shares outstanding - basic and diluted		39,445,268			31,428,233			38,810,985			30,876,709

	Six Months Ended December 31, 2020			Six Months Ended December 31, 2019

CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$	(23,860	)	$	(18,289	)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization		2,080			1,419
Common stock issued for services		4,093			3,305
Amortization of debt discount		2,346			1,490
Amortization of operating lease right of use asset		110			55
Non cash interest payments		488			488
Change in fair value of derivative liabilities		184			670
Change in fair value of contingent real estate liability		—			34
Changes in operating assets and liabilities:
Accounts receivable		(395	)		(841	)
Inventory		(515	)		—
Other current assets		(443	)		415
Other assets		—			(125	)
Accounts payable and accrued expenses		(204	)		(663	)
Lease liabilities		(111	)		(51	)
Deferred revenue		57			43
Net Cash Used in Operating Activities		(16,170	)		(12,050	)

CASH FLOWS FROM INVESTING ACTIVITIES:
Cash paid for machinery and equipment		(4,438	)		(4,171	)
Cash received from sale of fixed assets		—			28
Cash paid for intangibles		(53	)		(108	)
Net Cash Used in Investing Activities		(4,491	)		(4,251	)

CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of common stock		23,192			32,277
Proceeds from exercise of employee stock options		524			55
Proceeds from exercise of warrants		118			—
Proceeds from employee stock purchase plan		204			168
Net Cash Provided by Financing Activities		24,038			32,500

Net Increase (Decrease) in Cash, Cash Equivalents and Restricted Cash		3,377			16,199

Cash, Cash Equivalents and Restricted Cash - Beginning of Period		44,408			30,154

Cash, Cash Equivalents and Restricted Cash - End of Period	$	47,785		$	46,353

SUPPLEMENTARY CASH FLOW INFORMATION:
Cash Paid During the Period for:
Interest		325			325

SUPPLEMENTARY DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:

Common stock issued in payment of interest		488			488
Stock compensation payable		—			303
Fixed assets included in accounts payable and accrued expenses		572			1,128
Stock issuance costs included in accounts payable and accrued expenses		—			107
Reclass from assets held for sale		—			(251	)
Assets purchased using common stock		—			40

	Three Months 12/31/2020			Three Months 12/31/2019
Customer 1		18	%		—
Customer 2		29	%		—
Customer 3		32	%		55	%
Customer 4		15	%		29	%